TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16145306

Group type: EXPERIMENTAL
Intervention: 1 mg of oral estradiol combined with 25 microg of gestodene (oE2 + G, n = 33)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: 1 mg of oral estradiol (oE2, n = 37)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: 50 microg of transdermal 17ss-estradiol (tE2, n = 33)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo (n = 49)
Number of subjects: 152
Study: 11933727

Group type: EXPERIMENTAL
Intervention: Lyofoam/polyurethane foam dressing (Seton)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Aquagel/hydrogel dressing (Wytw.Opatrunków)
Number of subjects: 34
Study: 10517313

Group type: COMPARATOR
Intervention: IFN monotherapy (3 x 4.5 million units IFN‐alpha 2a per week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: IFN and N‐acetylcysteine (NAC) 1.800 mg/day) plus sodium selenite (400 microg/day) supplementation
Number of subjects: 24

Group type: COMPARATOR
Intervention: IFN, N‐acetylcysteine (NAC) 1.800 mg/day, sodium selenite (400 microg/day) plus vitamin E (544 IU/day)
Number of subjects: 24
Study: 8834093

Group type: COMPARATOR
Intervention: Placebo (2 ml 0.9% saline)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cortisol (50 mg)
Number of subjects: 10
Study: 1369949

Group type: EXPERIMENTAL
Intervention: Incorrect positioning of endoprosthesis elements
Number of subjects: 61
Study: 6946753

Group type: EXPERIMENTAL
Intervention: Smoking one cigarette during period 2 or period 3
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (pre-smoking period)
Number of subjects: 13
Study: 31856374

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 47
Study: 31801622

Group type: EXPERIMENTAL
Intervention: Integrated workplace mental health literacy and well-being programme delivered by a senior social worker over a period of 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-listed control group
Number of subjects: 0
Study: 29083969

Group type: EXPERIMENTAL
Intervention: Educational materials mailed to patients and physicians (cross-sectional cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational materials mailed to patients and physicians (longitudinal cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational materials mailed to patients and physicians (enhanced cohort)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No educational materials (control cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All cohorts
Number of subjects: 0
Study: 25354238

Group type: EXPERIMENTAL
Intervention: Sirolimus conversion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tacrolimus maintenance
Number of subjects: 30
Study: 23886761

Group type: EXPERIMENTAL
Intervention: Foot orthoses at the start of rehabilitation programme
Number of subjects: 14

Group type: COMPARATOR
Intervention: Foot orthoses at the end of intervention programme
Number of subjects: 14
Study: 21310836

Group type: EXPERIMENTAL
Intervention: Behavioral intervention to prevent excessive gestational weight gain (n = 201)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard care (n = 200)
Number of subjects: 401
Study: 19834961

Group type: EXPERIMENTAL
Intervention: Casopitant 50 mg plus ondansetron/dexamethasone
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Casopitant 100 mg plus ondansetron/dexamethasone
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Casopitant 150 mg plus ondansetron/dexamethasone
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Single-dose casopitant 150 mg plus ondansetron/dexamethasone
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Once-daily ondansetron plus casopitant
Number of subjects: 723

Group type: COMPARATOR
Intervention: Control group (ondansetron/dexamethasone only)
Number of subjects: 723
Study: 16696389

Group type: EXPERIMENTAL
Intervention: Ligasure hemorrhoidectomy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Closed hemorrhoidectomy
Number of subjects: 47
Study: 15572269

Group type: EXPERIMENTAL
Intervention: Amantadine (100-300 mg/day)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 12165818

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Preoperative cough score
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Change in cough on and off PPI
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Randomized acid infusion test
Number of subjects: 677
Study: 9917436

Group type: EXPERIMENTAL
Intervention: tracking/outreach
Number of subjects: 2741

Group type: COMPARATOR
Intervention: prompting
Number of subjects: 2741

Group type: COMPARATOR
Intervention: control
Number of subjects: 2741

Group type: EXPERIMENTAL
Intervention: prompting only
Number of subjects: 2741

Group type: EXPERIMENTAL
Intervention: combined prompting with tracking/outreach
Number of subjects: 2741
Study: 7496846

Group type: EXPERIMENTAL
Intervention: Anabolic-androgenic steroids
Number of subjects: 157

Group type: COMPARATOR
Intervention: Nonusers of anabolic-androgenic steroids
Number of subjects: 157

Group type: COMPARATOR
Intervention: Mr. America winners from the presteroid era (1939-1959)
Number of subjects: 157
Study: 2405743

Group type: EXPERIMENTAL
Intervention: Epidural morphine (5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intramuscular morphine (5 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 7363445

Group type: EXPERIMENTAL
Intervention: FPL57787
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31369328

Group type: EXPERIMENTAL
Intervention: Aquatic walking exercise (AQ) for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 72
Study: 28248619

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 1000
Study: 26108265

Group type: EXPERIMENTAL
Intervention: MA 60 mg/kg/d IM and oral placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MA 30 mg/kg/d IM and oral cimetidine 1200 mg/d
Number of subjects: 90

Group type: COMPARATOR
Intervention: MA 30 mg/kg/d IM and oral placebo
Number of subjects: 90
Study: 23895203

Group type: COMPARATOR
Intervention: Best Practices (BP)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Best Practices + Scheduled Reduced Smoking (BP + SRS)
Number of subjects: 185
Study: 22433035

Group type: EXPERIMENTAL
Intervention: 35% carbamide peroxide in a tray (TW)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 14% hydrogen peroxide in strips (WS)
Number of subjects: 24
Study: 19129293

Group type: EXPERIMENTAL
Intervention: Intensive support with CPAP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard support with CPAP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intensive support
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard support
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: APAP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 100
Study: 17588628

Group type: EXPERIMENTAL
Intervention: Gas chromatography/tandem mass spectrometry assay (GC/MS/MS)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Radioimmunoassay (RIA)
Number of subjects: 55
Study: 15364318

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: High-dose tirofiban
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: No glycoprotein (GP) IIb/IIIa inhibitor
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: GP IIb/IIIa inhibitor bolus followed by maintenance infusion
Number of subjects: 112
Study: 12373267

Group type: EXPERIMENTAL
Intervention: CAMP treatment
Number of subjects: 133
Study: 9649456

Group type: EXPERIMENTAL
Intervention: Low-impact exercise program of increasing intensity
Number of subjects: 117
Study: 8194619

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (hCG) with GnRH agonist
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 457

Group type: COMPARATOR
Intervention: Luteal phase support (general)
Number of subjects: 457

Group type: COMPARATOR
Intervention: hCG
Number of subjects: 457
Study: 2816239

Group type: EXPERIMENTAL
Intervention: 0.5% isoflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1% isoflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5% halothane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (0.5% isoflurane, 1% isoflurane, 0.5% halothane)
Number of subjects: 60
Study: 4614210

Group type: EXPERIMENTAL
Intervention: 15% fetal calf serum (FCS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: 10% fetal calf serum (FCS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: 5% fetal calf serum (FCS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: 15-30% fetal calf serum (FCS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Preliminary experiment (5-30% FCS)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Standard deviation estimates
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Mean AF cell growth
Number of subjects: 76
Study: 30260455

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1821

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 1821

Group type: COMPARATOR
Intervention: Bupropion
Number of subjects: 1821

Group type: COMPARATOR
Intervention: Nicotine gum
Number of subjects: 1821
Study: 29453304

Group type: EXPERIMENTAL
Intervention: QbTest protocol (experimental arm)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual (control arm)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 60
Study: 27525912

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANNs)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ward modified location model (MLM)
Number of subjects: 16
Study: 22577959

Group type: EXPERIMENTAL
Intervention: Platform-switched implant (test)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Platform-matched implant (control)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Both test and control implants
Number of subjects: 17
Study: 22248747

Group type: EXPERIMENTAL
Intervention: Intensive glucose control (IGC) to maintain glucose level between 6.1 mmol/L and 8.3 mmol/L
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 21034878

Group type: EXPERIMENTAL
Intervention: Behavioral interventions (two types)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 68
Study: 18803000

Group type: EXPERIMENTAL
Intervention: AMT 25 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: AMT 50 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 16040472

Group type: EXPERIMENTAL
Intervention: Combined manipulation, exercise, and physician consultation (combination group)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Physician consultation alone (consultation group)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Both groups (combination and consultation)
Number of subjects: 204
Study: 12015789

Group type: EXPERIMENTAL
Intervention: 30 mg gliclazide MR tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 mg gliclazide MR tablet under fasted conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 mg gliclazide MR tablet under fed conditions
Number of subjects: 0
Study: 10048061

Group type: EXPERIMENTAL
Intervention: New nerve root holders used during spinal decompression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contralateral approach
Number of subjects: 0
Study: 7552506

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2201941

Group type: EXPERIMENTAL
Intervention: Intramuscular methylprednisolone (4 mg/kg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 74
Study: 7318347

Group type: EXPERIMENTAL
Intervention: Metoprolol (100-200 mg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pindolol (5-10 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 36
Study: 31015275

Group type: EXPERIMENTAL
Intervention: Counselling session, information booklet, continuous support by a researcher
Number of subjects: 140

Group type: COMPARATOR
Intervention: Contact information of local support services
Number of subjects: 140
Study: 29768070

Group type: EXPERIMENTAL
Intervention: Web-based Help Program for Drug Abuse and Depression
Number of subjects: 74

Group type: COMPARATOR
Intervention: In-person session with addiction therapist and treatment as usual
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment ordinarily offered in participating treatment centers
Number of subjects: 74
Study: 27352487

Group type: EXPERIMENTAL
Intervention: Wheat-size moxibustion therapy (9 moxa cones on Zusanli (ST 36) and Feishu (BL 13) acupoints, once a day for 6 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (follow-up visit without treatment)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of observation group vs control group after treatment
Number of subjects: 70
Study: 25342209

Group type: EXPERIMENTAL
Intervention: Yoga intervention (12 week program with two group sessions and one home session per week, led by an experienced instructor, involving hatha yoga sequence with asana, pranayama, and meditation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment wait-list control group
Number of subjects: 0
Study: 22719882

Group type: EXPERIMENTAL
Intervention: Tenofovir/emtricitabine (TDF-FTC)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Abacavir/lamivudine (ABC-3TC)
Number of subjects: 301
Study: 20205950

Group type: EXPERIMENTAL
Intervention: Family-centred tobacco control program delivered over three home visits in the first three months of the infant's life.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group) which does not receive the tobacco control program.
Number of subjects: 0
Study: 17628251

Group type: EXPERIMENTAL
Intervention: Cervical headgear
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Jasper jumper
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 75
Study: 16199419

Group type: EXPERIMENTAL
Intervention: Pressure controlled ventilation (PCV) with PEEP=5 cm H(2)O
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pressure controlled ventilation (PCV) without PEEP
Number of subjects: 20
Study: 12005084

Group type: EXPERIMENTAL
Intervention: Menjugate vaccine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Meningitec vaccine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (routine vaccines only)
Number of subjects: 100
Study: 10886586

Group type: EXPERIMENTAL
Intervention: 14G needle
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 16G needle
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 18G needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: All three needle sizes
Number of subjects: 100
Study: 9118688

Group type: EXPERIMENTAL
Intervention: Risk factors identified in logistic regression
Number of subjects: 400
Study: 1560801

Group type: EXPERIMENTAL
Intervention: Amitriptyline (105 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Desipramine (111 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 2862315

Group type: EXPERIMENTAL
Intervention: Active treatment (15 mg [50 000 IU] retinol, 200 mg riboflavine, and 50 mg zinc)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610
Study: 29926533

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1185
Study: 29426328

Group type: EXPERIMENTAL
Intervention: Mediterranean lemonade
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Green Tea
Number of subjects: 50

Group type: COMPARATOR
Intervention: Flavored water control
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Study beverage (Mediterranean lemonade, Green Tea)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fasting blood samples
Number of subjects: 50
Study: 27281373

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for SAD (CBT-SAD)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Light therapy (LT)
Number of subjects: 177
Study: 23631951

Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive remediation (CACR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Computer games (CG)
Number of subjects: 32
Study: 23288753

Group type: EXPERIMENTAL
Intervention: Cut technique of hamstring tendon harvesting
Number of subjects: 34

Group type: COMPARATOR
Intervention: Push technique of hamstring tendon harvesting
Number of subjects: 34
Study: 19013564

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (non-DMPA users)
Number of subjects: 64
Study: 18784156

Group type: EXPERIMENTAL
Intervention: Eculizumab (600 mg weekly for 4 weeks, then 900 mg at week 5 and every 14 days thereafter)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 16608805

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 5
Study: 12889683

Group type: EXPERIMENTAL
Intervention: High sense of coherence (SOC) tertile
Number of subjects: 4405

Group type: COMPARATOR
Intervention: Low sense of coherence (SOC) tertile
Number of subjects: 4405

Group type: EXPERIMENTAL
Intervention: Low SOC tertile among white-collar workers
Number of subjects: 4405

Group type: EXPERIMENTAL
Intervention: Low SOC tertile among blue-collar workers
Number of subjects: 4405
Study: 10781777

Group type: EXPERIMENTAL
Intervention: clarithromycin (500 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: trimethoprim-sulfamethoxazole (800/160 mg)
Number of subjects: 24
Study: 8971284

Group type: EXPERIMENTAL
Intervention: 0.2 mg nitroglycerine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.4 mg nitroglycerine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.8 mg nitroglycerine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1280091

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg b.i.d.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg o.d.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 31159799

Group type: EXPERIMENTAL
Intervention: Lower tourniquet pressure (SBP + 120 mmHg)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Conventional tourniquet pressure (SBP + 150 mmHg)
Number of subjects: 124
Study: 28026887

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 88

Group type: COMPARATOR
Intervention: Left-lateral position
Number of subjects: 88

Group type: COMPARATOR
Intervention: Right-lateral position
Number of subjects: 88

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 88
Study: 27125139

Group type: EXPERIMENTAL
Intervention: Intensive Mind and Body Therapeutic Program (MBT)
Number of subjects: 108
Study: 24016370

Group type: EXPERIMENTAL
Intervention: CST PTP group (preclinical simulation course)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Interval group (clinical training + simulation training)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (only clinical training)
Number of subjects: 30
Study: 21246067

Group type: EXPERIMENTAL
Intervention: RelyXTM Unicem (Ucem, self-adhesive) with MDP-based primer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM ARC (ARC, conventional) with MDP-based primer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM Unicem (Ucem, self-adhesive) with Rocatec system
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM ARC (ARC, conventional) with Rocatec system
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM Unicem (Ucem, self-adhesive) with no treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM ARC (ARC, conventional) with no treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM Unicem (Ucem, self-adhesive) with airborne-particle abrasion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyXTM ARC (ARC, conventional) with airborne-particle abrasion
Number of subjects: 40
Study: 19671139

Group type: EXPERIMENTAL
Intervention: escitalopram 10 mg per day
Number of subjects: 80

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 80
Study: 17096115

Group type: EXPERIMENTAL
Intervention: Lean women
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Upper-body-obese (UBO) women
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Lower-body-obese (LBO) women
Number of subjects: 46

Group type: COMPARATOR
Intervention: Obese women (UBO and LBO)
Number of subjects: 46
Study: 15030422

Group type: EXPERIMENTAL
Intervention: CARTO
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional
Number of subjects: 102
Study: 12370212

Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of autologous mononuclear bone marrow cells (BMCs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 10
Study: 9532318

Group type: EXPERIMENTAL
Intervention: Yoga techniques (breathing and relaxation techniques, pranayama, yogasanas, meditation) taught three times a week for 16 weeks.
Number of subjects: 17

Group type: COMPARATOR
Intervention: Nonyoga control group (no specific intervention details provided).
Number of subjects: 17
Study: 7916004

Group type: EXPERIMENTAL
Intervention: Metoprolol (14/190 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2481883

Group type: EXPERIMENTAL
Intervention: Moderate hypervolaemic haemodilution with Hydroxyethyl starch 200/0.5 6%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 5472804

Group type: EXPERIMENTAL
Intervention: Morning glycaemia
Number of subjects: 162

Group type: COMPARATOR
Intervention: Afternoon glucose tolerance tests
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Degree of diurnal variation
Number of subjects: 162